The Morrison government went against departmental advice to continue negotiating with another tenderer for mRNA vaccines and ...

The FDA probe is more extensive than previously understood, as it encompasses both adult and pediatric cases. "FDA is doing a thorough investigation, across multiple age groups, of deaths potentially ...

Vinay Prasad, a top FDA official, blamed COVID shots for playing a role in the deaths of 10 children in a memo he sent to ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 6.4% in the afternoon session after a major long-term study from ...

Moderna and other vaccine stocks tumbled Monday after an FDA director reportedly issued a memo that says Covid shots killed ...

Moderna (MRNA) slipped about 6% after an FDA official said future vaccine approvals will face tougher scrutiny, a shift tied ...

The vaccines received Emergency Use Authorization (EUA) in December 2020 after only 20 weeks of testing, authors write. The highly atypical trial protocol was part of a “declared health emergency,” as ...

Moderna said Wednesday that its experimental mRNA-based seasonal flu vaccine generated a stronger immune response against four strains of the flu virus than a currently marketed vaccine in a Phase 3 ...

Vaccine experts said the memo was irresponsible and omits key details about how officials arrived at the conclusion.

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

Moderna Inc. fell Monday after the Food and Drug Administration said in a memo late last week it would place new restrictions on which vaccines hit the market.

Moderna Inc. fell in premarket trading Monday after the Food and Drug Administration said in a memo late last week it would place new restrictions on which vaccines hit the market.